financetom
Business
financetom
/
Business
/
Venu Holding Insider Bought Shares Worth $250,000, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Venu Holding Insider Bought Shares Worth $250,000, According to a Recent SEC Filing
Mar 12, 2026 1:42 PM

04:29 PM EDT, 03/12/2026 (MT Newswires) -- Jay W Roth, 10% Owner, Director, CEO & Chairman, on March 10, 2026, executed a purchase for 62,500 shares in Venu Holding ( VENU ) for $250,000. Following the Form 4 filing with the SEC, Roth has control over a total of 10,315,864 common shares of the company, with 9,253,644 shares held directly and 1,062,220 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1770501/000149315226009864/xslF345X05/ownership.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Market Chatter: Biden to Wait for Results of National Security Review Before Acting on Nippon-US Steel Deal
Update: Market Chatter: Biden to Wait for Results of National Security Review Before Acting on Nippon-US Steel Deal
Dec 11, 2024
08:54 AM EST, 12/11/2024 (MT Newswires) -- (Updates with US Steel's response in the third paragraph.) President Joe Biden will wait to see the results of an ongoing national security review of Nippon Steel's bid to acquire US Steel (X) before deciding whether to block it, Reuters reported Wednesday, citing a statement from the White House. Reuters reported a White...
AnaptysBio Says Phase 2B Trial in Atopic Dermatitis Failed to Meet Endpoints
AnaptysBio Says Phase 2B Trial in Atopic Dermatitis Failed to Meet Endpoints
Dec 11, 2024
08:57 AM EST, 12/11/2024 (MT Newswires) -- AnaptysBio ( ANAB ) said Wednesday that it would discontinue further investment in experimental therapy ANB032 after a phase 2b trial in moderate-to-severe atopic dermatitis or eczema did not meet the primary and secondary endpoints. The company said it would focus its resources and capital on its other investigational autoimmune drugs. AnaptysBio (...
Albertsons Sues Kroger for Alleged Breach of Merger Agreement
Albertsons Sues Kroger for Alleged Breach of Merger Agreement
Dec 11, 2024
08:52 AM EST, 12/11/2024 (MT Newswires) -- Albertsons ( ACI ) said Wednesday it terminated its merger agreement with Kroger ( KR ) and filed a lawsuit against the grocer for allegedly breaching their merger agreement after a federal judge in Oregon blocked the deal on Tuesday. Kroger ( KR ) willfully breached the Merger Agreement in several key ways,...
Asset Entities Shares Increase After TikTok Partnership
Asset Entities Shares Increase After TikTok Partnership
Dec 11, 2024
08:58 AM EST, 12/11/2024 (MT Newswires) -- Asset Entities ( ASST ) shares were up more than 19% in recent Wednesday premarket activity after the company said it had been approved as an official TikTok Shop Partner. The status means it will now partner with TikTok to connect brands and sponsors to influencers and content creators on the social media...
Copyright 2023-2026 - www.financetom.com All Rights Reserved